Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.

Saved in:
Bibliographic Details
Title: Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Authors: Charles-Schoeman, Christina1 (AUTHOR) ccharles@mednet.ucla.edu, Giles, Jon T.2 (AUTHOR), Lane, Nancy E.3 (AUTHOR), Choy, Ernest4 (AUTHOR), Furst, Daniel E.5 (AUTHOR), Vencovský, Jiří6,7 (AUTHOR), Wilson, Anthony G.8 (AUTHOR), Burmester, Gerd R.9 (AUTHOR), Coombs, Derek10 (AUTHOR), Penn, Sara K.10 (AUTHOR), Khan, Nasser10 (AUTHOR), Yee, Jillian B.10 (AUTHOR), Rahawi, Kassim10 (AUTHOR), McInnes, Iain B.11 (AUTHOR)
Source: Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p157-175. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-023-00624-3